HEADER HYDROLASE/HYDROLASE INHIBITOR 31-MAR-21 7MAS TITLE DRUG RESISTANT HIV-1 PROTEASE (L10F, M46I, I50V, F53L, L63P, G73S) IN TITLE 2 COMPLEX WITH DRV COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTEASE; COMPND 3 CHAIN: B, D, C, A; COMPND 4 FRAGMENT: UNP RESIDUES 501-599; COMPND 5 SYNONYM: PR,RETROPEPSIN; COMPND 6 EC: 3.4.23.16; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 GROUP M SOURCE 3 SUBTYPE B; SOURCE 4 ORGANISM_COMMON: HIV-1; SOURCE 5 ORGANISM_TAXID: 11686; SOURCE 6 STRAIN: ISOLATE BRU/LAI; SOURCE 7 GENE: GAG-POL; SOURCE 8 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 9 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS DRUG RESISTANCE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR G.J.LOCKBAUM,C.A.SCHIFFER REVDAT 2 18-OCT-23 7MAS 1 REMARK REVDAT 1 09-NOV-22 7MAS 0 JRNL AUTH G.J.LOCKBAUM,C.A.SCHIFFER JRNL TITL DRUG RESISTANT HIV-1 PROTEASE (L10F, M46I, I50V, F53L, L63P, JRNL TITL 2 G73S) IN COMPLEX WITH DRV JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 1.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.14_3260 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 46.34 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.360 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.1 REMARK 3 NUMBER OF REFLECTIONS : 66075 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.203 REMARK 3 R VALUE (WORKING SET) : 0.202 REMARK 3 FREE R VALUE : 0.225 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 3.030 REMARK 3 FREE R VALUE TEST SET COUNT : 2000 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 46.3350 - 3.6147 0.97 4712 148 0.1830 0.2070 REMARK 3 2 3.6147 - 2.8692 0.97 4627 144 0.1854 0.1819 REMARK 3 3 2.8692 - 2.5066 0.98 4606 143 0.1984 0.2387 REMARK 3 4 2.5066 - 2.2774 0.99 4604 144 0.1937 0.2207 REMARK 3 5 2.2774 - 2.1142 0.99 4625 144 0.1855 0.2148 REMARK 3 6 2.1142 - 1.9895 0.99 4627 145 0.1865 0.2139 REMARK 3 7 1.9895 - 1.8899 0.98 4557 142 0.2039 0.2216 REMARK 3 8 1.8899 - 1.8076 0.98 4515 141 0.2289 0.2491 REMARK 3 9 1.8076 - 1.7380 0.97 4553 143 0.2498 0.3174 REMARK 3 10 1.7380 - 1.6781 0.98 4565 142 0.2606 0.2948 REMARK 3 11 1.6781 - 1.6256 0.98 4541 141 0.2689 0.2946 REMARK 3 12 1.6256 - 1.5791 0.99 4537 142 0.2761 0.2924 REMARK 3 13 1.5791 - 1.5375 0.98 4574 143 0.3091 0.3634 REMARK 3 14 1.5375 - 1.5000 0.96 4432 138 0.3421 0.3776 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.220 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 25.810 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 28.11 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.011 3124 REMARK 3 ANGLE : 1.184 4262 REMARK 3 CHIRALITY : 0.078 514 REMARK 3 PLANARITY : 0.009 530 REMARK 3 DIHEDRAL : 11.652 1836 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7MAS COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 31-MAR-21. REMARK 100 THE DEPOSITION ID IS D_1000255799. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 20-MAR-19 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 23-ID-D REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.07812 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 66102 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.500 REMARK 200 RESOLUTION RANGE LOW (A) : 46.335 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.1 REMARK 200 DATA REDUNDANCY : 1.800 REMARK 200 R MERGE (I) : 0.04900 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 7.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.55 REMARK 200 COMPLETENESS FOR SHELL (%) : 96.6 REMARK 200 DATA REDUNDANCY IN SHELL : 1.60 REMARK 200 R MERGE FOR SHELL (I) : 0.52100 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.100 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 6DGX REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 49.48 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.43 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 3.3-3.5 M NACL, 0.1 M TRIS-HCL PH 8.5, REMARK 280 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 18.14000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4770 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 9330 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -30.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4770 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 9390 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -32.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: D, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS B 14 CG CD CE NZ REMARK 470 ARG B 41 CG CD NE CZ NH1 NH2 REMARK 470 LYS B 70 CG CD CE NZ REMARK 470 LYS D 14 CG CD CE NZ REMARK 470 ARG D 41 CG CD NE CZ NH1 NH2 REMARK 470 LYS C 14 CG CD CE NZ REMARK 470 ARG C 41 CG CD NE CZ NH1 NH2 REMARK 470 LYS C 43 CG CD CE NZ REMARK 470 LYS A 14 CG CD CE NZ REMARK 470 GLU A 21 CG CD OE1 OE2 REMARK 470 LYS A 43 CG CD CE NZ REMARK 470 LYS A 45 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH A 298 O HOH A 301 1.93 REMARK 500 O HOH A 262 O HOH A 305 1.96 REMARK 500 O HOH B 153 O HOH A 292 1.98 REMARK 500 O HOH D 175 O HOH C 254 2.00 REMARK 500 O HOH A 247 O HOH A 297 2.08 REMARK 500 O HOH C 228 O HOH C 281 2.13 REMARK 500 O HOH B 109 O HOH B 117 2.13 REMARK 500 O HOH C 258 O HOH C 296 2.14 REMARK 500 O HOH A 257 O HOH A 280 2.16 REMARK 500 OG1 THR B 4 O HOH B 101 2.18 REMARK 500 O HOH D 135 O HOH D 146 2.19 REMARK 500 O HOH B 146 O HOH A 280 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O HOH D 119 O HOH C 271 2444 2.00 REMARK 500 O HOH D 119 O HOH C 222 2444 2.08 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO B 79 48.92 -82.71 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH D 194 DISTANCE = 6.17 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 017 C 101 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 017 A 101 DBREF 7MAS B 1 99 UNP P03367 POL_HV1BR 501 599 DBREF 7MAS D 1 99 UNP P03367 POL_HV1BR 501 599 DBREF 7MAS C 1 99 UNP P03367 POL_HV1BR 501 599 DBREF 7MAS A 1 99 UNP P03367 POL_HV1BR 501 599 SEQADV 7MAS LYS B 7 UNP P03367 GLN 507 CONFLICT SEQADV 7MAS PHE B 10 UNP P03367 LEU 510 ENGINEERED MUTATION SEQADV 7MAS ASN B 37 UNP P03367 SER 537 CONFLICT SEQADV 7MAS ILE B 46 UNP P03367 MET 546 ENGINEERED MUTATION SEQADV 7MAS VAL B 50 UNP P03367 ILE 550 ENGINEERED MUTATION SEQADV 7MAS LEU B 53 UNP P03367 PHE 553 ENGINEERED MUTATION SEQADV 7MAS PRO B 63 UNP P03367 LEU 563 ENGINEERED MUTATION SEQADV 7MAS SER B 73 UNP P03367 GLY 573 ENGINEERED MUTATION SEQADV 7MAS LYS D 7 UNP P03367 GLN 507 CONFLICT SEQADV 7MAS PHE D 10 UNP P03367 LEU 510 ENGINEERED MUTATION SEQADV 7MAS ASN D 37 UNP P03367 SER 537 CONFLICT SEQADV 7MAS ILE D 46 UNP P03367 MET 546 ENGINEERED MUTATION SEQADV 7MAS VAL D 50 UNP P03367 ILE 550 ENGINEERED MUTATION SEQADV 7MAS LEU D 53 UNP P03367 PHE 553 ENGINEERED MUTATION SEQADV 7MAS PRO D 63 UNP P03367 LEU 563 ENGINEERED MUTATION SEQADV 7MAS SER D 73 UNP P03367 GLY 573 ENGINEERED MUTATION SEQADV 7MAS LYS C 7 UNP P03367 GLN 507 CONFLICT SEQADV 7MAS PHE C 10 UNP P03367 LEU 510 ENGINEERED MUTATION SEQADV 7MAS ASN C 37 UNP P03367 SER 537 CONFLICT SEQADV 7MAS ILE C 46 UNP P03367 MET 546 ENGINEERED MUTATION SEQADV 7MAS VAL C 50 UNP P03367 ILE 550 ENGINEERED MUTATION SEQADV 7MAS LEU C 53 UNP P03367 PHE 553 ENGINEERED MUTATION SEQADV 7MAS PRO C 63 UNP P03367 LEU 563 ENGINEERED MUTATION SEQADV 7MAS SER C 73 UNP P03367 GLY 573 ENGINEERED MUTATION SEQADV 7MAS LYS A 7 UNP P03367 GLN 507 CONFLICT SEQADV 7MAS PHE A 10 UNP P03367 LEU 510 ENGINEERED MUTATION SEQADV 7MAS ASN A 37 UNP P03367 SER 537 CONFLICT SEQADV 7MAS ILE A 46 UNP P03367 MET 546 ENGINEERED MUTATION SEQADV 7MAS VAL A 50 UNP P03367 ILE 550 ENGINEERED MUTATION SEQADV 7MAS LEU A 53 UNP P03367 PHE 553 ENGINEERED MUTATION SEQADV 7MAS PRO A 63 UNP P03367 LEU 563 ENGINEERED MUTATION SEQADV 7MAS SER A 73 UNP P03367 GLY 573 ENGINEERED MUTATION SEQRES 1 B 99 PRO GLN ILE THR LEU TRP LYS ARG PRO PHE VAL THR ILE SEQRES 2 B 99 LYS ILE GLY GLY GLN LEU LYS GLU ALA LEU LEU ASP THR SEQRES 3 B 99 GLY ALA ASP ASP THR VAL LEU GLU GLU MET ASN LEU PRO SEQRES 4 B 99 GLY ARG TRP LYS PRO LYS ILE ILE GLY GLY VAL GLY GLY SEQRES 5 B 99 LEU ILE LYS VAL ARG GLN TYR ASP GLN ILE PRO ILE GLU SEQRES 6 B 99 ILE CYS GLY HIS LYS ALA ILE SER THR VAL LEU VAL GLY SEQRES 7 B 99 PRO THR PRO VAL ASN ILE ILE GLY ARG ASN LEU LEU THR SEQRES 8 B 99 GLN ILE GLY CYS THR LEU ASN PHE SEQRES 1 D 99 PRO GLN ILE THR LEU TRP LYS ARG PRO PHE VAL THR ILE SEQRES 2 D 99 LYS ILE GLY GLY GLN LEU LYS GLU ALA LEU LEU ASP THR SEQRES 3 D 99 GLY ALA ASP ASP THR VAL LEU GLU GLU MET ASN LEU PRO SEQRES 4 D 99 GLY ARG TRP LYS PRO LYS ILE ILE GLY GLY VAL GLY GLY SEQRES 5 D 99 LEU ILE LYS VAL ARG GLN TYR ASP GLN ILE PRO ILE GLU SEQRES 6 D 99 ILE CYS GLY HIS LYS ALA ILE SER THR VAL LEU VAL GLY SEQRES 7 D 99 PRO THR PRO VAL ASN ILE ILE GLY ARG ASN LEU LEU THR SEQRES 8 D 99 GLN ILE GLY CYS THR LEU ASN PHE SEQRES 1 C 99 PRO GLN ILE THR LEU TRP LYS ARG PRO PHE VAL THR ILE SEQRES 2 C 99 LYS ILE GLY GLY GLN LEU LYS GLU ALA LEU LEU ASP THR SEQRES 3 C 99 GLY ALA ASP ASP THR VAL LEU GLU GLU MET ASN LEU PRO SEQRES 4 C 99 GLY ARG TRP LYS PRO LYS ILE ILE GLY GLY VAL GLY GLY SEQRES 5 C 99 LEU ILE LYS VAL ARG GLN TYR ASP GLN ILE PRO ILE GLU SEQRES 6 C 99 ILE CYS GLY HIS LYS ALA ILE SER THR VAL LEU VAL GLY SEQRES 7 C 99 PRO THR PRO VAL ASN ILE ILE GLY ARG ASN LEU LEU THR SEQRES 8 C 99 GLN ILE GLY CYS THR LEU ASN PHE SEQRES 1 A 99 PRO GLN ILE THR LEU TRP LYS ARG PRO PHE VAL THR ILE SEQRES 2 A 99 LYS ILE GLY GLY GLN LEU LYS GLU ALA LEU LEU ASP THR SEQRES 3 A 99 GLY ALA ASP ASP THR VAL LEU GLU GLU MET ASN LEU PRO SEQRES 4 A 99 GLY ARG TRP LYS PRO LYS ILE ILE GLY GLY VAL GLY GLY SEQRES 5 A 99 LEU ILE LYS VAL ARG GLN TYR ASP GLN ILE PRO ILE GLU SEQRES 6 A 99 ILE CYS GLY HIS LYS ALA ILE SER THR VAL LEU VAL GLY SEQRES 7 A 99 PRO THR PRO VAL ASN ILE ILE GLY ARG ASN LEU LEU THR SEQRES 8 A 99 GLN ILE GLY CYS THR LEU ASN PHE HET 017 C 101 75 HET 017 A 101 75 HETNAM 017 (3R,3AS,6AR)-HEXAHYDROFURO[2,3-B]FURAN-3-YL(1S,2R)-3- HETNAM 2 017 [[(4-AMINOPHENYL)SULFONYL](ISOBUTYL)AMINO]-1-BENZYL-2- HETNAM 3 017 HYDROXYPROPYLCARBAMATE HETSYN 017 DARUNAVIR; TMC114; UIC-94017 FORMUL 5 017 2(C27 H37 N3 O7 S) FORMUL 7 HOH *413(H2 O) HELIX 1 AA1 GLY B 86 THR B 91 1 6 HELIX 2 AA2 GLY D 86 THR D 91 1 6 HELIX 3 AA3 GLY C 86 ILE C 93 1 8 HELIX 4 AA4 GLY A 86 ILE A 93 1 8 SHEET 1 AA1 4 GLN B 2 ILE B 3 0 SHEET 2 AA1 4 THR A 96 ASN A 98 -1 O LEU A 97 N ILE B 3 SHEET 3 AA1 4 THR B 96 ASN B 98 -1 N ASN B 98 O THR A 96 SHEET 4 AA1 4 GLN A 2 ILE A 3 -1 O ILE A 3 N LEU B 97 SHEET 1 AA2 8 TRP B 42 GLY B 49 0 SHEET 2 AA2 8 GLY B 52 ILE B 66 -1 O GLN B 58 N LYS B 43 SHEET 3 AA2 8 HIS B 69 VAL B 77 -1 O HIS B 69 N ILE B 66 SHEET 4 AA2 8 VAL B 32 LEU B 33 1 N LEU B 33 O LEU B 76 SHEET 5 AA2 8 ILE B 84 ILE B 85 -1 O ILE B 84 N VAL B 32 SHEET 6 AA2 8 GLN B 18 LEU B 24 1 N LEU B 23 O ILE B 85 SHEET 7 AA2 8 PHE B 10 ILE B 15 -1 N ILE B 13 O LYS B 20 SHEET 8 AA2 8 GLY B 52 ILE B 66 -1 O GLU B 65 N LYS B 14 SHEET 1 AA3 4 GLN D 2 ILE D 3 0 SHEET 2 AA3 4 THR C 96 ASN C 98 -1 O LEU C 97 N ILE D 3 SHEET 3 AA3 4 THR D 96 ASN D 98 -1 N ASN D 98 O THR C 96 SHEET 4 AA3 4 GLN C 2 ILE C 3 -1 O ILE C 3 N LEU D 97 SHEET 1 AA4 8 LYS D 43 GLY D 49 0 SHEET 2 AA4 8 GLY D 52 ILE D 66 -1 O GLN D 58 N LYS D 43 SHEET 3 AA4 8 HIS D 69 VAL D 77 -1 O HIS D 69 N ILE D 66 SHEET 4 AA4 8 VAL D 32 LEU D 33 1 N LEU D 33 O LEU D 76 SHEET 5 AA4 8 ILE D 84 ILE D 85 -1 O ILE D 84 N VAL D 32 SHEET 6 AA4 8 GLN D 18 LEU D 24 1 N LEU D 23 O ILE D 85 SHEET 7 AA4 8 PHE D 10 ILE D 15 -1 N ILE D 13 O LYS D 20 SHEET 8 AA4 8 GLY D 52 ILE D 66 -1 O GLU D 65 N LYS D 14 SHEET 1 AA5 8 LYS C 43 GLY C 49 0 SHEET 2 AA5 8 GLY C 52 ILE C 66 -1 O GLN C 58 N LYS C 43 SHEET 3 AA5 8 LYS C 70 VAL C 77 -1 O VAL C 75 N TYR C 59 SHEET 4 AA5 8 VAL C 32 LEU C 33 1 N LEU C 33 O LEU C 76 SHEET 5 AA5 8 ILE C 84 ILE C 85 -1 O ILE C 84 N VAL C 32 SHEET 6 AA5 8 GLN C 18 LEU C 24 1 N LEU C 23 O ILE C 85 SHEET 7 AA5 8 PHE C 10 ILE C 15 -1 N ILE C 13 O LYS C 20 SHEET 8 AA5 8 GLY C 52 ILE C 66 -1 O GLU C 65 N LYS C 14 SHEET 1 AA6 8 TRP A 42 GLY A 49 0 SHEET 2 AA6 8 GLY A 52 ILE A 66 -1 O GLN A 58 N LYS A 43 SHEET 3 AA6 8 HIS A 69 VAL A 77 -1 O VAL A 75 N TYR A 59 SHEET 4 AA6 8 VAL A 32 LEU A 33 1 N LEU A 33 O LEU A 76 SHEET 5 AA6 8 ILE A 84 ILE A 85 -1 O ILE A 84 N VAL A 32 SHEET 6 AA6 8 GLN A 18 LEU A 24 1 N LEU A 23 O ILE A 85 SHEET 7 AA6 8 PHE A 10 ILE A 15 -1 N ILE A 13 O LYS A 20 SHEET 8 AA6 8 GLY A 52 ILE A 66 -1 O GLU A 65 N LYS A 14 SITE 1 AC1 24 ASP C 25 GLY C 27 ALA C 28 ASP C 29 SITE 2 AC1 24 ASP C 30 GLY C 48 GLY C 49 VAL C 50 SITE 3 AC1 24 ILE C 84 HOH C 216 ARG D 8 ASP D 25 SITE 4 AC1 24 GLY D 27 ALA D 28 ASP D 30 GLY D 48 SITE 5 AC1 24 GLY D 49 VAL D 50 PRO D 81 VAL D 82 SITE 6 AC1 24 ILE D 84 HOH D 104 HOH D 136 HOH D 139 SITE 1 AC2 18 ASP A 25 GLY A 27 ALA A 28 ASP A 29 SITE 2 AC2 18 ASP A 30 GLY A 48 GLY A 49 VAL A 50 SITE 3 AC2 18 HOH A 227 ASP B 25 GLY B 27 ALA B 28 SITE 4 AC2 18 ASP B 30 GLY B 48 GLY B 49 PRO B 81 SITE 5 AC2 18 ILE B 84 HOH B 104 CRYST1 56.739 36.280 103.508 90.00 98.66 90.00 P 1 21 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017625 0.000000 0.002684 0.00000 SCALE2 0.000000 0.027563 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009772 0.00000